Alitair Pharmaceuticals, Inc. — Form D

Alitair Pharmaceuticals, Inc. of MORRISTOWN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-30. The offering totals $938K, of which $911K was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2015-09-30
Form: D
Accession: 0001654448-15-000002
Industry: Pharmaceuticals
Exemptions: 04
Total offering: $938K
Amount sold: $911K
Remaining: $27K
Minimum investment: $5K
Investors: 18
Date of first sale: 2015-09-15
Security types: equity
Revenue range: $1,000,001 - $5,000,000
SEC file number: 021-248476

Issuer

Name: Alitair Pharmaceuticals, Inc.
CIK: 0001654448
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 55 MADISON STREET, MORRISTOWN, NJ, 07960
Phone: 973-984-1669

Officers, directors & promoters (6)

Name	Role	Location
Robert E Casale	Director	Morristown, NJ
James E Hoyes	Director	Morristown, NJ
James E Hoyes	Executive Officer	Morristown, NJ
Frank E Guarino	Executive Officer	Morristown, NJ
William W Howard	Director	Morristown, NJ
William W Howard	Executive Officer	Morristown, NJ

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2020-11-13	D	$31.0M	$35K
2018-10-09	D	$32.0M	$115K
2017-07-03	D	$5.0M	—
2017-03-10	D	$3.1M	$100K

More